Company news
Lotus Pharmaceutical Co., Ltd. news in 2024
Lotus Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2024, newest first.
Lotus Reported Unaudited November Revenues of NT$1,061 million, YTD Revenue Surpassing the Total Revenue for 2023
December 11, 2024
Lotus Reported Unaudited September Revenues of NT$1,187 million
October 14, 2024
Lotus Reported Unaudited July Revenues of NT$2,722 million, second-highest monthly revenue in the company's history
August 12, 2024
Lotus Pharmaceutical Honored 2024 Taiwan BIO Awards- Outstanding Company of the Year, Showcasing Excellence in Operational Performance, Development Strategy, and Technological Innovation
July 29, 2024
Lotus Reported Unaudited December Consolidated Revenues of NT$1,372 million, showcasing MoM and YoY Growth 2023 Unaudited Consolidated Revenues Grew 16% to NT$16,958 million, marking 5th consecutive year of double-digit growth
January 11, 2024